|
|||||
|
|
Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry |
|
| Authors: | Kihara Mari Sugihara Takahiko Asano Junichi Sato Midori Kaneko Hiroshi Muraoka Sei Ohshima Shiro Nanki Toshihiro |
| Institution: | 1.Department of Rheumatology, Tokyo Medical and Dental University, Tokyo, Japan ;2.Pharmaceuticals and Medical Devices Agency, Office of Pharmacovigilance II, Tokyo, Japan ;3.Graduate School of Medical and Dental Science, Department of Lifetime Clinical Immunology, Tokyo Medical and Dental University, Tokyo, Japan ;4.Pharmaceuticals and Medical Devices Agency, Office of New Drug IV, Tokyo, Japan ;5.Graduate School of Medical and Dental Sciences, Department of Clinical Biostatistics, Tokyo Medical and Dental University, Tokyo, Japan ;6.Department of Respiratory Medicine, National Hospital Organization Tokyo Medical Centre, Tokyo, Japan ;7.Division of Rheumatic Disease, National Centre for Global Health and Medicine, Tokyo, Japan ;8.Department of Internal Medicine, Ebara Hospital, Tokyo Metropolitan Health and Hospitals Corporation, Tokyo, Japan ;9.Department of Clinical Research, National Hospital Organization Osaka Minami Medical Centre, Kawachinagano, Japan ;10.Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan ; |
| Abstract: | Clinical Rheumatology - To describe clinical characteristics of patients in Japan with coronavirus disease 19 (COVID-19) and pre-existing rheumatic disease and examine the possible risk factors... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |